* VitaResc AG, of Martinsried, Germany, and Evotec OAI AG, of Hamburg, Germany, extended their collaboration related to development of VitaResc's antithrombotic drug VTR-RI. The initial agreement was signed in the summer of 2000. The companies have developed a protocol for high-yield …
Комментариев нет:
Отправить комментарий